NGF and Alzheimer disease: Inspection of Table 4 clearly shows that the percentage of samples having a detectable NGF peak is significantly higher in FTD, SMC, and CTR than in the AD group (proportions test, p < 0.0001), with the SMC and CTR diagnostic groups exhibiting the highest percentage of detectable NGF peak.